Article Details
Retrieved on: 2021-04-16 14:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Similar to ICIs, therapeutic monoclonal antibodies designed to target inhibitory receptors on the surface of NK cells are also of great interest. To date ...
Article found on: www.onclive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here